A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence
- PMID: 17152090
- DOI: 10.1002/syn.20356
A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence
Abstract
Previous studies established that Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol (DAMGO) and (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho-[2,1-c]pyran-7-carboxylic acid methyl ester (herkinorin) are fully efficacious mu-agonists. Herkinorin (HERK), unlike DAMGO, does not recruit beta-arrestin and promote mu-receptor internalization, even in cells that over express beta-arrestin. We hypothesized that chronic HERK and DAMGO treatment will differentially affect cellular markers of tolerance and dependence. CHO cells expressing the cloned human mu-receptor were treated for 20 h with 10 microM DAMGO, HERK, morphine, or medium. Both DAMGO and HERK acted as full agonists in the [(35)S]GTP-gamma-S binding assay with E(MAX) values of 230% and EC(50) values of 12.8 and 92.5 nM, respectively. In the cAMP assay, DAMGO and HERK had similar E(MAX) values of approximately 80% and EC(50) values of 3.23 and 48.7 nM, respectively. Chronic exposure to both drugs produced moderate tolerance to both drugs ( approximately 2 to 5 fold) in the [(35)S]GTP-gamma-S binding assay. In the cAMP assay, chronic DAMGO produced tolerance to both drugs ( approximately 3 to 4 fold). Chronic HERK eliminated the ability of either drug to inhibit forskolin-stimulated cAMP accumulation. Chronic DAMGO increased, and chronic HERK decreased, forskolin-stimulated cAMP accumulation. Naloxone, after chronic HERK (but not DAMGO) induced a large increase in forskolin-stimulated cAMP accumulation. Viewed collectively with published data, the current data indicate that both internalizing and noninternalizing mu-agonists produce cellular signs of tolerance and dependence.
Similar articles
-
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.Synapse. 2010 Apr;64(4):280-8. doi: 10.1002/syn.20723. Synapse. 2010. PMID: 19953652 Free PMC article.
-
Salvinorin A: allosteric interactions at the mu-opioid receptor.J Pharmacol Exp Ther. 2007 Feb;320(2):801-10. doi: 10.1124/jpet.106.113167. Epub 2006 Oct 23. J Pharmacol Exp Ther. 2007. PMID: 17060492
-
Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.Synapse. 2004 Jun 1;52(3):209-17. doi: 10.1002/syn.20019. Synapse. 2004. PMID: 15065220
-
Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.Br J Pharmacol. 2012 Mar;165(6):1704-1716. doi: 10.1111/j.1476-5381.2011.01482.x. Br J Pharmacol. 2012. PMID: 21564086 Free PMC article. Review.
-
Opioid regulation of mu receptor internalisation: relevance to the development of tolerance and dependence.CNS Neurol Disord Drug Targets. 2010 Nov;9(5):616-26. doi: 10.2174/187152710793361522. CNS Neurol Disord Drug Targets. 2010. PMID: 20632966 Review.
Cited by
-
Salvinorin A analogs as probes in opioid pharmacology.Chem Rev. 2008 May;108(5):1732-43. doi: 10.1021/cr0782269. Chem Rev. 2008. PMID: 18476672 Free PMC article. Review. No abstract available.
-
Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT1A) Receptors Heterodimerization and Cellular Effectors (Ca2+, ERK1/2 and p38) Activation.Molecules. 2022 Apr 6;27(7):2350. doi: 10.3390/molecules27072350. Molecules. 2022. PMID: 35408749 Free PMC article.
-
The effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primates.J Pharmacol Exp Ther. 2008 Oct;327(1):154-60. doi: 10.1124/jpet.108.140079. Epub 2008 Jul 1. J Pharmacol Exp Ther. 2008. PMID: 18593955 Free PMC article.
-
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Pharmacol Rev. 2011. PMID: 21444610 Free PMC article. Review.
-
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.Pharmacol Rev. 2011 Dec;63(4):1001-19. doi: 10.1124/pr.111.004598. Epub 2011 Aug 26. Pharmacol Rev. 2011. PMID: 21873412 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials